WebAug 4, 2024 · Second quarter revenue of $5.8 million, a decrease of 70% compared to prior year period, due to the impact of COVID-19 Ended the quarter with appr... WebAug 1, 2024 · Second quarter revenue of $26.1 million, an increase of 36% compared to prior year periodContinued growth from both the Tuberculosis and Tick-borne disease... Oxford Immunotec Reports Second ...

Oxford Immunotec Reports Third Quarter 2024 Financial

WebOxford Immunotec is a global, high-growth diagnostics company focused on developing and commercializing proprietary assays for immunology and infectious disease. WebRevenue. $27.9M. Industry. Business Services General. Business Services. Trade Tech's Social Media. Is this data correct? View contact profiles from Trade Tech. Popular … lafazkan kalimah cintamu ep 13

Oxford Immunotec Q4 Revenues Grow 18 Percent 360Dx

WebOxford Immunotec, a medical diagnostics company, develops tests for various diseases based on its innovative T cell measurement technology. Acquired by PerkinElmer Abingdon, Oxfordshire, United Kingdom 251-500 … WebMay 5, 2024 · Oxford Immunotec (OXFD) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.06 … WebOct 13, 2016 · Business Outlook We expect the acquisition of Immunetics to contribute approximately $0.5 million in revenues in the fourth quarter of 2016. We continue to expect to report full year 2016 revenue of between $82.5 and $84.5 million. We expect to have over $50 million of cash at the end of 2016, excluding any draw-downs on our debt revolver. jede jede mašinka